carlisle medical
Refill Requests shipment tracking contact carlisle medical
Knowledge Center
Industrial related news
FDA bans generic version of Oxycontin
Released: 04/17/2013
By: Mike Partridge, RPh

On the day when the patent for the original version of OxyContin was set to expire the Food and Drug Administration said Tuesday that it would not approve generic versions of the powerful narcotic Oxycontin.
The move represents a victory for OxyContin’s manufacturer, Purdue Pharma, which in 2010 introduced a formulation of the drug that was less prone to tampering.
The original version of OxyContin, which was approved in late 1995, could be easily crushed, a step that released its entire narcotic payload at once rather than over time as intended. The new version turns into a jellylike mass when crushed.

The decision is likely to result in higher prices for OxyContin, a time-release form of a narcotic called oxycodone, because it will not face generic competition.



<<Back
 
Company News
Generic Releases
Industry Related News
Industry Related Links
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2018 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer